Navigation Links
Discoveries Brighten Search for AIDS Vaccine

Two antibodies appear effective against HIV subtypes worldwide, team says

THURSDAY, Sept. 3 (HealthDay News) -- After recent setbacks, the search for an effective AIDS vaccine may have gotten a much needed shot in the arm with the discovery of two highly potent targets for immunization.

A team coordinated by the International AIDS Vaccine Initiative (IAVI) says they've discovered two immune-system antibodies in the blood of an African person with HIV that might offer protection against strains of the virus circulating worldwide.

These antibodies target a spot on HIV that is both easily accessed and "highly conserved," meaning it does not seem to change over time.

The findings, announced in the Sept. 4 issue of Science, may be "a new lease on life, a new key towards accelerating AIDS vaccine development," said Wayne Koff, senior vice president of research and development for IAVI, which is based in New York City.

Antibodies, immune cell-generated molecules that mark invading pathogens for destruction, are the lynchpin of any effective vaccine. Vaccines work by spurring the body to produce copious amounts of targeted antibodies when the real invader -- the flu, measles, or other such germ -- appears.

But the search for a vaccine against HIV has been perhaps the toughest yet. That's because it mutates so rapidly and "is different all over the world at a scale that's dwarfed any other virus," Koff said. In fact, experts estimate that the pool of HIV circulating in one infected person contains as many variants as all of the flu viruses circulating globally in a given year.

In recent years, the only two AIDS vaccine candidates that have made it to clinical trials have failed, causing some to doubt whether an effective shot might ever be found.

Four other antibodies to HIV were identified earlier, the last one over a decade ago. However, according to Rowena Johnston, director of research at the Foundation for AIDS Research (amfAR), those antibodies were only effective against the subtypes of HIV chiefly found in the United States or Europe, not in the developing world, where the majority of HIV-infected people now live.

In contrast, the new antibodies, dubbed PG9 and PG16, "are active against a whole range of clades, or types of viruses that you are likely to encounter all around the world, rather than just one specific region of the world," Johnston said.

And while the antibodies discovered earlier latched onto HIV at tough-to-reach spots on the virus, PG9 and PG16 target a much more accessible point. According to Johnston, that should mean that "you don't need to produce as many of the antibodies for them to be effective as you do with the other antibodies. So, it's within a much more realistic range for a vaccine that would get your body to pump out a sufficient number of antibodies [to shield against HIV]."

The process by which the IAVI-led team discovered the antibodies is also a departure for AIDS research, Koff said. His group used cutting-edge technologies developed by two U.S. biotech companies, Theraclone Sciences and Monogram Biosciences, to comb through blood samples from over 1,800 HIV-infected people living in countries around the world. The two new antibodies were discovered by IAVI researchers in the blood of one African donor.

This approach could reveal more -- and, potentially, even better -- antibodies in the future, Koff said. "It's going to yield a lot of fruit in the coming months," he said. "We presume that as we screen other donors now that we are going to find other antibodies and targets on HIV."

Still, an effective vaccine against AIDS is not right around the corner, the experts said, and it could still be years before any tried-and-true vaccine candidate emerges.

"The road to a vaccine is going to be a long and arduous one," Johnston stressed. "This is a step along that road."

More information

Find out more about HIV/AIDS at the U.S. National Institute of Allergy and Infectious Diseases.

SOURCES: Wayne Koff, Ph.D., senior vice president, research and development, International AIDS Vaccine Initiative (IAVI), New York City; Rowena Johnston, Ph.D., director, research, Foundation for AIDS Research (amfAR), New York City; Sept. 4, 2009, Science

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FASgen Announces New Research Discoveries in Lung Cancer
2. MSU researchers make new discoveries on what does and doesnt affect immune system
3. X-rays power discoveries at Chicagos Field Museum
4. Recent Genetic Discoveries Dont Improve Prediction of Breast Cancer
5. Spiders, frogs and gecko among exciting discoveries found in Papua New Guinea
6. Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit
7. Stemedica Selected by World Stem Cell Summit to Present Scientific Discoveries
8. Green fireworks may brighten eco-friendly 4th of July displays in future
9. Chicago Cosmetic Dentistry Practice Offers Ultra-Thin, Futuristic Lumineers Dental Veneers to Brighten Smiles
10. Corbin Bleu Asks Fans to Join Him in Brightening the Lives of Seriously Ill Children
11. Stanford researchers find culprit in aging muscles that heal poorly
Post Your Comments:
Related Image:
Discoveries Brighten Search for AIDS Vaccine
(Date:11/25/2015)... Cleveland, OH (PRWEB) , ... November 25, 2015 , ... ... dental implants in Cleveland, OH , are invited to attend Dr. Mark Iacobelli’s Advanced ... 5th this year in Cleveland, OH. , As the co-founders of Advanced Implant ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... The McHenry ... a recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. ... v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - ... surgeon specializing in both surgical and non-surgical treatments, announced the expansion of his ... Facial Plastic Surgery. , Highly trained and nationally recognized for his natural ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... provide scholarships for people struggling with eating disorders as a result of the ... second annual event, held at Fox Run Golf Club in Eureka, will help ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 26, 2015  The total global healthcare industry ... over 2015-2016. Latin America has the ... , (excluding Japan ), is second with ... continues to face increased healthcare expenditure. In 2013-2014, total government ... from 43.5% in 2008-2009 to 41.2% in 2013-2014. In real ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
(Date:11/25/2015)... November 25, 2015 Kitov Pharma ... (TASE: KTOV), a biopharmaceutical company focused on the development ... clinical conditions, today announced the closing of its previously ... ( ADSs ), each representing 20 ordinary shares of ... ADSs. The ADSs and warrants were issued in a ...
Breaking Medicine Technology: